Cargando…

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?

Coronaviruses (CoVs) are a group of viruses from the family Coronaviridae that can infect humans and animals, causing mild to severe diseases. The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global threat, urging the development of new therapeutic st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Igor de Andrade, Grosche, Victória Riquena, Bergamini, Fernando Rodrigues Goulart, Sabino-Silva, Robinson, Jardim, Ana Carolina Gomes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438404/ https://www.ncbi.nlm.nih.gov/pubmed/32903349 http://dx.doi.org/10.3389/fmicb.2020.01818

Ejemplares similares

Antivirals Against Chikungunya Virus: Is the Solution in Nature?
por: Oliveira Silva Martins, Daniel, et al.
Publicado: (2020)

An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets
por: Paschoalino, Marina, et al.
Publicado: (2023)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics
por: Grosche, Victória Riquena, et al.
Publicado: (2021)

Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways
por: Ruiz, Uriel Enrique Aquino, et al.
Publicado: (2022)

Molecular characterization and sequecing analysis of SARS-CoV-2 genome in Minas Gerais, Brazil
por: Ferreira, Giulia Magalhães, et al.
Publicado: (2022)

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
por: Oliveira, Tales Lyra, et al.
Publicado: (2020)

Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis
por: Sabino-Silva, Robinson, et al.
Publicado: (2020)

Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells
por: de Oliveira, Débora Moraes, et al.
Publicado: (2020)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
por: Al-Khalaifah, Hanan, et al.
Publicado: (2022)

Modulation of Innate Antiviral Immune Response by Porcine Enteric Coronavirus
por: Zhang, Kunli, et al.
Publicado: (2022)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)

The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
por: Tse, Longping V., et al.
Publicado: (2020)

Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil
por: Adeboyejo, Kazeem, et al.
Publicado: (2022)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022)

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
por: Hentzien, Maxime, et al.
Publicado: (2022)

G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2
por: Cui, Haoran, et al.
Publicado: (2020)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
por: Tzou, Philip L., et al.
Publicado: (2020)

Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
por: Wang, Yi, et al.
Publicado: (2021)

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
por: Wang, Wen-Xin, et al.
Publicado: (2022)

Editorial: Human coronavirus research: 20 years since the SARS-CoV outbreak
por: Fielding, Burtram C.
Publicado: (2022)

In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2
por: Sberna, Giuseppe, et al.
Publicado: (2022)

Plant-derived antivirals against hepatitis c virus infection
por: Jardim, Ana Carolina Gomes, et al.
Publicado: (2018)

Hydroelectrolytic Disorder in COVID-19 patients: Evidence Supporting the Involvement of Subfornical Organ and Paraventricular Nucleus of the Hypothalamus
por: de Melo, Igor Santana, et al.
Publicado: (2021)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses
por: Khrustalev, Vladislav Victorovich, et al.
Publicado: (2020)

What Goes Around, Comes Around – HSV-1 Replication in Monocyte-Derived Dendritic Cells
por: Grosche, Linda, et al.
Publicado: (2017)

Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2
por: Kumar, K. M., et al.
Publicado: (2023)

Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
por: Săndulescu, Oana, et al.
Publicado: (2023)

Rhipicephalus bursa Sialotranscriptomic Response to Blood Feeding and Babesia ovis Infection: Identification of Candidate Protective Antigens
por: Antunes, Sandra, et al.
Publicado: (2018)

Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice
por: Zhang, Lilin, et al.
Publicado: (2022)

Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity
por: Matos, Aline da Rocha, et al.
Publicado: (2022)

Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo
por: Andreu, Sabina, et al.
Publicado: (2023)

Oral Infection, Oral Pathology and Salivary Diagnostics of Mpox Disease: Relevance in Dentistry and OMICs Perspectives
por: Garcia-Junior, Marcelo Augusto, et al.
Publicado: (2023)

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
por: Zhou, Nan, et al.
Publicado: (2016)

Druggable targets from coronaviruses for designing new antiviral drugs
por: Silva, Leandro Rocha, et al.
Publicado: (2020)

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics
por: Khalid, Zunera, et al.
Publicado: (2022)

Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections
por: Behzadi, Mohammad Amin, et al.
Publicado: (2019)

Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13
por: Lv, Longxian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_llrfdru7h9c6t21is6aha90hiu